{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Congenital+Heart+Disease&page=3", "query": { "condition": "Congenital Heart Disease", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 1106, "total_pages": 111, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Congenital+Heart+Disease&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Congenital+Heart+Disease&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T11:08:13.912Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02862600", "title": "Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cardiomyopathy, Hypertrophic", "Cardiomyopathy, Hypertrophic, Familial" ], "interventions": [ { "name": "Perhexiline", "type": "DRUG" }, { "name": "Use of bioanalytical assay to monitor plasma levels of perhexiline", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Heart Metabolics Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2016-08-01", "completion_date": "2017-05-22", "has_results": true, "last_update_posted_date": "2017-08-31", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 11, "location_summary": "Stanford, California • Indianapolis, Indiana • Baltimore, Maryland + 7 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02862600" }, { "nct_id": "NCT00308217", "title": "Single Ventricle Outcome", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Disease, Congenital", "Single Ventricle", "Hypoplastic Left Heart Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 30, "start_date": "2005-06", "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2013-12-12", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00308217" }, { "nct_id": "NCT03533517", "title": "Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure", "Cardiomyopathy, Dilated" ], "interventions": [ { "name": "AccuCinch® Ventricular Restoration", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ancora Heart, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2018-08-23", "completion_date": "2026-02-28", "has_results": false, "last_update_posted_date": "2025-01-30", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 18, "location_summary": "San Francisco, California • Atlanta, Georgia • Louisville, Kentucky + 14 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Houma", "state": "Louisiana" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03533517" }, { "nct_id": "NCT01367834", "title": "Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Turner Syndrome" ], "interventions": [ { "name": "somatotropin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rebecca Knickmeyer Santelli, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "11 Months", "maximum_age": "13 Months", "sex": "FEMALE", "summary": "11 Months to 13 Months · Female only" }, "enrollment_count": 17, "start_date": "2010-05", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2017-03-24", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01367834" }, { "nct_id": "NCT03406884", "title": "The CHILD Trial: Hypoplastic Left Heart Syndrome Study.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypoplastic Left Heart Syndrome" ], "interventions": [ { "name": "c-kit+ cells", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Joshua M Hare", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "21 Days", "sex": "ALL", "summary": "1 Day to 21 Days" }, "enrollment_count": 25, "start_date": "2019-10-16", "completion_date": "2024-07-01", "has_results": true, "last_update_posted_date": "2026-01-23", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 4, "location_summary": "Atlanta, Georgia • Chicago, Illinois • Baltimore, Maryland + 1 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03406884" }, { "nct_id": "NCT00706849", "title": "Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heterozygous Familial Hypercholesterolemia", "Coronary Artery Disease" ], "interventions": [ { "name": "mipomersen sodium", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kastle Therapeutics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 124, "start_date": "2008-07", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2016-09-09", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 37, "location_summary": "La Jolla, California • Los Angeles, California • Mission Viejo, California + 31 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00706849" }, { "nct_id": "NCT03945643", "title": "Is Blood Flow Through IPAVA and PFO Related to Breath-hold and SCUBA Diving-induced Pulmonary Hypertension?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Patent Foramen Ovale", "Intrapulmonary Arteriovenous Anastamosis" ], "interventions": [ { "name": "Sildenafil", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Oregon", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 82, "start_date": "2019-07-01", "completion_date": "2023-07-31", "has_results": false, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 1, "location_summary": "Eugene, Oregon", "locations": [ { "city": "Eugene", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03945643" }, { "nct_id": "NCT01045356", "title": "Pharmacokinetics of Tranexamic Acid (TXA) in Children Undergoing Repair of Congenital Heart Defects Utilizing Cardiopulmonary Bypass", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Congenital Heart Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 55, "start_date": "2010-01", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-07-30", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01045356" }, { "nct_id": "NCT07295730", "title": "3D Modalities for Medical Student Education of Congenital Heart Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tetralogy of Fallot (TOF)", "Hypoplastic Left Heart Syndrome (HLHS)" ], "interventions": [ { "name": "3D-printed heart models and augmented reality", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Case Western Reserve University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2025-11-20", "completion_date": "2025-12-09", "has_results": false, "last_update_posted_date": "2025-12-26", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07295730" }, { "nct_id": "NCT05246709", "title": "Impact of Cyanoacrylate Glue on PICC Line Dressing Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Central Line Complication", "Neonatal Disease" ], "interventions": [ { "name": "Cyanoacrylate glue", "type": "DEVICE" }, { "name": "Standard transparent film dressing", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "6 Months", "sex": "ALL", "summary": "1 Day to 6 Months" }, "enrollment_count": 32, "start_date": "2022-02-26", "completion_date": "2022-11-16", "has_results": true, "last_update_posted_date": "2025-06-26", "last_synced_at": "2026-10-07T11:08:13.912Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05246709" } ] }